Vincent A, Roberts M, Willison H, Lang B, Newsom-Davis J
Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.
J Physiol Paris. 1995;89(3):129-36. doi: 10.1016/0928-4257(96)80110-0.
Myasthenia gravis, the Lambert-Eaton myasthenic syndrome, and acquired neuromyotonia are three disorders of the neuromuscular junction or motor nerve that are caused by autoantibodies to ion channel proteins: acetylcholine receptors, voltage-gated calcium channels and voltage-gated potassium channels, respectively. The antibody titres can be measured using the relevant 125I-neurotoxins to label the extracted channels. Other disorders of the peripheral motor nerve are associated with antibodies to gangliosides. Sera with raised levels of anti-ganglioside antibodies have direct effects on the function of the distal motor nerve and motor nerve terminal. These conditions can be improved by therapies designed to reduce circulating antibodies. Antibodies that bind to neuronal surface antigens are proving to be of great clinical importance and interest in neurological disorders.
重症肌无力、兰伯特-伊顿肌无力综合征和获得性神经性肌强直是神经肌肉接头或运动神经的三种疾病,分别由针对离子通道蛋白(乙酰胆碱受体、电压门控钙通道和电压门控钾通道)的自身抗体引起。抗体滴度可以使用相关的125I-神经毒素标记提取的通道来测量。外周运动神经的其他疾病与针对神经节苷脂的抗体有关。抗神经节苷脂抗体水平升高的血清对远端运动神经和运动神经末梢的功能有直接影响。这些病症可以通过旨在减少循环抗体的疗法得到改善。事实证明,与神经元表面抗原结合的抗体在神经疾病中具有重要的临床意义和研究价值。